Company Filing History:
Years Active: 2013
Title: Keren Paz: Innovator in Cancer Treatment
Introduction
Keren Paz is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative work on antibodies.
Latest Patents
Keren Paz holds 1 patent for his invention titled "c-Kit antibodies and uses thereof." This invention is directed to antibodies that specifically bind to an extracellular domain of human c-Kit. The pharmaceutical compositions comprising these antibodies are designed for use in treating cancer.
Career Highlights
Keren Paz is currently associated with Imclone LLC, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective treatments that can improve patient outcomes in oncology.
Collaborations
Keren collaborates with talented professionals in his field, including Michael Amatulli and Laura Ann Breen (nee Brennan). Their combined expertise contributes to the innovative environment at Imclone LLC.
Conclusion
Keren Paz is a dedicated inventor whose work on c-Kit antibodies represents a significant advancement in cancer treatment. His contributions are paving the way for new therapeutic options in the fight against cancer.